Baloxavir marboxil
Xofluza (baloxavir marboxil) is a small molecule pharmaceutical. Baloxavir marboxil was first approved as Xofluza on 2018-10-24. It is used to treat influenza a virus and influenza b virus in the USA. It has been approved in Europe to treat human influenza. Xofluza's patents are valid until 2037-08-09 (FDA).
| Trade Name | Xofluza |
|---|---|
| Common Name | Baloxavir marboxil |
| Indication | human influenza, influenza a virus, influenza b virus |
| Drug Class | Antivirals |
